Search

Clinical Research

Category

los angeles

Kite Earns Patent for Method to Increase Efficacy of CAR-T

Kite Earns Patent for Method to Increase Efficacy of CAR-T  Genetic Engineering & Biotechnology NewsFull coverage https://www.genengnews.com/gen-exclusives/kite-earns-patent-for-method-to-increase-efficacy-of-car-t/77901032

Advertisements

FDA signs off on Atara’s IND for MS candidate ATA188

FDA signs off on Atara’s IND for MS candidate ATA188  Investing.comFull coverage https://www.investing.com/news/stock-market-news/fda-signs-off-on-ataras-ind-for-ms-candidate-ata188-1086581

HemaCare Announces OneBlood Exercises Second Investment Tranche Option

HemaCare Announces OneBlood Exercises Second Investment Tranche Option  Digital JournalFull coverage http://www.digitaljournal.com/pr/3614428

MedMen Launches ‘Faces’ Cannabis Ad Campaign in California

MedMen Launches ‘Faces’ Cannabis Ad Campaign in California  GanjapreneurFull coverage https://www.ganjapreneur.com/medmen-launches-faces-cannabis-ad-campaign-in-california/

Atara Starts Two Phase 3 Trials of Treatment for Lymphoma That Arises from a Transplant

Atara Starts Two Phase 3 Trials of Treatment for Lymphoma That Arises from a Transplant  Lymphoma News TodayFull coverage https://lymphomanewstoday.com/2018/01/04/atara-to-test-lymphoma-treatment-for-transplant-recipients-in-two-phase-3-trials/

MedMen One of First Marijuana Shops Open in WeHo

MedMen One of First Marijuana Shops Open in WeHo  NBC Southern CaliforniaFull coverage https://www.nbclosangeles.com/on-air/as-seen-on/MedMen-One-of-First-Marijuana-Shops-Open-in-WeHo_Los-Angeles-467674053.html

Atara Biotherapeutics Shares Rise on FDA Approval

Atara Biotherapeutics Shares Rise on FDA Approval  San Fernando Valley Business JournalAtara Biotherapeutics Gets FDA Approval and Stock Climbs Over 20%  MicroSmallCap (press release)Full coverage http://sfvbj.com/news/2017/dec/29/atara-biopharmaceutics-shares-rise-fda-approval/

Emmaus Life Sciences Sickle Cell Treatment Receives Positive Opinion on Pediatric Investigation Plan from European …

Emmaus Life Sciences Sickle Cell Treatment Receives Positive Opinion on Pediatric Investigation Plan from European …  Business Wire (press release)Full coverage https://www.businesswire.com/news/home/20171221006139/en/Emmaus-Life-Sciences-Sickle-Cell-Treatment-Receives

Opiant Pharmaceuticals Announces Significant Financial Developments Related to NARCAN® Nasal Spray for Opioid …

Opiant Pharmaceuticals Announces Significant Financial Developments Related to NARCAN® Nasal Spray for Opioid …  GlobeNewswire (press release)Opiant to receive 90% of Narcan payments directly from Adapt Pharma starting next quarter; shares ahead 32%  Seeking AlphaFull coverage https://globenewswire.com/news-release/2017/12/20/1266946/0/en/Opiant-Pharmaceuticals-Announces-Significant-Financial-Developments-Related-to-NARCAN-Nasal-Spray-for-Opioid-Overdose.html

Create a free website or blog at WordPress.com.

Up ↑

%d bloggers like this: